Clinical trials
Evaluation clinical trials
Below are recruiting evaluation clinical trials, each written for real people, not researchers. We’re tracking 5,340 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07535385Recruiting
Kidney Artery Blocking Treatment for Polycystic Kidney Disease
This study follows patients with a genetic kidney disease (autosomal dominant polycystic kidney disease) who are on dialysis and receive a procedure to block blood flow to their enlarged kidneys. Researchers will track how well the procedure works and how it affects patients over time using imaging scans.
Pavia, LombardyAges 18–75 - NCT07535541Recruiting
Smartwatch Study of Hot Flashes in Prostate Cancer Patients
This study tests whether a smartwatch can accurately measure hot flashes (sudden heat and sweating) that occur in men undergoing hormone therapy for prostate cancer. You'll wear the smartwatch for about 4 weeks while the research team tracks your symptoms.
Charlottesville, VirginiaAges 18 years+ - NCT07535554RecruitingPhase 2/Phase 3
New PET scan to detect inflammation in three conditions
This study tests a new type of PET scan (a medical imaging test) that may better detect inflammation in the body compared to the standard scan currently used. Researchers will compare the two scans in patients with fever of unknown origin, IgG4-related disease, or inflammatory back pain.
LeuvenAges 18 years+ - NCT07535606RecruitingPhase 1
Safety Study of ALN-4915 in Healthy Adults
This is an early-stage study testing a new investigational medicine called ALN-4915 in healthy volunteers. Researchers want to learn if it is safe and how the body processes it.
LondonAges 18–65 - NCT07537517Recruiting
Understanding heart failure and blood vessel pressure changes
This research study examines how certain biological pathways work in patients with heart failure who need heart catheterization (a procedure to measure heart pressures). By understanding these pathways, researchers hope to develop better treatments for pulmonary hypertension, a condition where blood pressure in the lungs becomes dangerously high.
Madrid, MadridAges 18 years+ - NCT07538128RecruitingEarly Phase 1
New drug YSCH-01 with immunotherapy for recurrent brain cancer
This early-stage trial tests a new drug called YSCH-01, alone or combined with an immunotherapy drug (atezolizumab), for glioblastoma that has come back after previous treatment. The study places a small tube in the brain to deliver the drug directly and monitors safety and how well it works.
Shanghai, Shanghai MunicipalityAges 18 years+ - NCT07538570RecruitingPhase 4
Pain Management After Knee Replacement Surgery
This study tests different pain treatments for patients undergoing total knee replacement surgery. The goal is to find the most effective way to manage pain after this common procedure.
Bellaire, TexasAges 18–80 - NCT07538648RecruitingPhase 1
Imaging Dye for Surgery to Find Solid Tumors
This study tests a new injectable dye (NC527-X) that helps surgeons see tumors better during surgery. The dye glows under special light, making it easier to find and remove cancer tissue completely.
Hangzhou, ZhejiangAges 18 years+ - NCT07538726Recruiting
Early weight-bearing after pelvic fracture surgery
This study tests whether patients can safely put weight on their leg earlier than usual after pelvic fracture surgery, and whether this helps them recover movement and function faster. Researchers will compare early partial weight-bearing to standard care.
Asyut, Asyut GovernorateAges 18–55 - NCT07539090RecruitingPhase 1
How a new drug affects birth control effectiveness
This study tests whether a new medicine called vimseltinib changes how your body processes birth control pills. Understanding this interaction helps doctors know if the pill remains effective when taken together with this drug.
Saint Paul, MinnesotaAges 18–55 - NCT07539792RecruitingPhase 2
New Skull Support Plates for Pituitary Tumor Surgery
This study tests a new type of absorbable (dissolvable) support plate used during minimally invasive surgery to remove tumors in the pituitary gland area. The plate helps support the surgical site as it heals. Researchers want to see if this new plate works safely and effectively compared to standard approaches.
Foshan, GuangdongAges 1–80 - NCT07540754RecruitingPhase 1
How Your Liver Processes a New Injection Medicine
This study tests how your body processes a new medicine called HRS9531 when injected. Researchers want to understand how liver function affects the medicine's breakdown, which helps them determine safe doses for future patients.
Zhengzhou, HenanAges 18–65 - NCT07540884Recruiting
Comparing two artificial tear eye drops for dry eyes
This study tests whether two versions of Tears Naturale® eye drops work well for mild to moderate dry eye disease. You'll use only the study drops for the full study period to see which one helps your symptoms most.
Burnaby, British ColumbiaAges 18 years+ - NCT07541911Recruiting
Confocal Microscopy to Check Prostate Cancer Surgery Margins
This study tests whether a special microscope can help surgeons see cancer margins (edges) during prostate removal surgery to make sure all cancer is removed. It may help surgeons make real-time decisions about how much tissue to remove.
LondonAges 18 years+ - NCT07542756RecruitingPhase 4
Testing Common Sleep Medications for Insomnia
This study compares how well different over-the-counter and prescription sleep medications work for insomnia. Researchers will guide you through trying medications one at a time to find what works best for your sleep problems.
Philadelphia, PennsylvaniaAges 18–80 - NCT07544030RecruitingPhase 3
PIPAC chemotherapy for advanced ovarian cancer
This study tests a new way to deliver chemotherapy directly into the abdomen (called PIPAC) for women with advanced ovarian cancer who cannot have surgery to remove all tumors. The goal is to see if this approach is safe and helps slow cancer growth.
Changchun, JilinAges 18–70 - NCT07544589RecruitingPhase 1
Testing DISP-10 for Advanced Gastrointestinal Cancers
This early-stage trial tests a new experimental therapy called DISP-10 in patients with advanced cancers of the stomach, esophagus, or colon that have spread. The goal is to see if this treatment can help shrink tumors and how safe it is.
Duarte, CaliforniaAges 18 years+ - NCT07546591Recruiting
Lactoferrin supplement study for female endurance athletes
This study tests whether a natural protein called lactoferrin can improve iron levels and athletic performance in women who exercise regularly. If you're a female runner, cyclist, or swimmer with low iron stores, this trial might help you feel stronger during training.
Saint Charles, MissouriAges 18–45 - NCT07547553RecruitingPhase 1/Phase 2
HH-009 for Advanced Liver Cancer with FGF19 Marker
This trial tests a new drug called HH-009 for advanced or inoperable liver cancer (hepatocellular carcinoma, or HCC) that has a specific genetic marker called FGF19. The drug is designed to target this marker and may help slow or shrink the cancer in people whose disease has gotten worse despite previous treatment.
Bengbu, AnhuiAges 18–75 - NCT07547748Recruiting
Eye health services for rural children in China
This study tests a new way to provide eye care services in rural areas of China for children ages 3–18. Researchers want to see if bringing eye exams and vision services to schools and local communities helps more children get the eye care they need.
Lincang, YunnanAges 3–18 - NCT07547891Recruiting
Ultrasound elastography for kidney swelling in pregnancy
This study tests a special ultrasound technique to evaluate kidney swelling (hydronephrosis) that causes flank pain during pregnancy. The goal is to better understand kidney changes in pregnant women and help doctors decide on treatment.
Banī Suwayf, Beni Suef GovernorateAges 18 years+ - NCT07548632RecruitingPhase 2/Phase 3
Testing a new eye drop medicine for dry eye disease
This study tests whether licaminlimab, a new type of eye drop medicine, helps relieve dry eye disease. You'll use the study medicine for several weeks while doctors track how your symptoms and eye health improve.
Aliso Viejo, CaliforniaAges 18 years+ - NCT07549919RecruitingPhase 1
Food Effects on a New Experimental Drug in Healthy Men
This study tests how food affects how the body absorbs and processes a new experimental drug called AJ201. Researchers will give the drug to healthy men with and without food to see if it makes a difference, and they'll check for any side effects.
Los Alamitos, CaliforniaAges 18–55 - NCT07551024Recruiting
Zygomatic Implant Placement Accuracy: Metallic vs Resin Guides
This study compares two types of surgical guides (metallic and resin-based) to help dentists place zygomatic implants—special dental anchors used when the upper jaw bone is severely worn down. The goal is to see which guide method places these implants more accurately.
New Cairo, Cairo GovernorateAges 18 years+
Hear when a new Evaluation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for evaluation?
- Yes. Clin2 currently lists 5,340 recruiting evaluation studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a evaluation trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a evaluation trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.